International General Insurance Holdings (IGIC)·Q4 2025 Earnings Summary

IGI Q4 2025: EPS Miss, But Record Capital Returns and S&P Upgrade Highlight Strength

February 25, 2026 · by Fintool AI Agent

International General Insurance Holdings (NASDAQ: IGIC) reported Q4 2025 results that missed EPS estimates but showcased the specialty insurer's consistent execution and shareholder-friendly capital allocation. Net income rose 7.7% year-over-year to $32.3 million despite lower gross written premiums, while the company returned a record $108 million to shareholders and secured an S&P rating upgrade to A (Stable).

---

Did IGI Beat Earnings?

EPS: Miss by 4.4% — IGI reported EPS of $0.87 versus consensus of $0.91.*

*Values retrieved from S&P Global

The miss was driven by a higher combined ratio and lower net premiums earned versus the prior year quarter, partially offset by strong net investment income of $14.6 million.

Full Year 2025:

• Net Income: $127.2M (-5.9% vs FY 2024)
• Combined Ratio: 85.9% (vs 79.9% FY 2024)
• Core Operating ROE: 16.8% (vs 24.2% FY 2024)

The FY decline reflects a $24 million negative FX impact and higher catastrophe losses, though the 10-year average Core Operating ROE of 14.5% demonstrates consistent long-term profitability.

---

How Did the Stock React?

IGI shares closed at $25.38 on February 24, up 1.5% ahead of earnings. The stock has gained 22% over the past year, outperforming the broader insurance sector. With aftermarket trading at $25.77 (+1.5%), initial reaction appears muted despite the EPS miss.

*Beat/miss percentages and reactions based on available estimate and price data.

---

What Did Management Highlight?

1. S&P Rating Upgrade to A (Stable)

S&P raised IGI's financial strength rating to A (Stable) in 2025, recognizing the company's track record of profitability and disciplined underwriting. This places IGI among the strongest-rated specialty insurers globally.

2. Record Capital Returns

IGI returned a record $108.1 million to shareholders in FY 2025:

• Dividends: $46.2M (including $0.85 special dividend)
• Share Repurchases: $61.9M (2.6M shares)
• Quarterly dividend doubled to $0.05 per share
• Total shares repurchased since 2022: 7.8 million

3. Zero Leverage, Strong Balance Sheet

IGI maintains zero financial debt, a rarity in the insurance industry. Combined with a $710 million capital base and $1.3 billion investment portfolio, the balance sheet supports continued growth and capital returns.

---

What Changed From Last Quarter?

*Values retrieved from S&P Global

Key Changes:

• Gross written premiums rebounded sequentially (+13.7%) but remain below prior year Q4 ($174.6M) as IGI continues disciplined cycle management
• Combined ratio improved 0.8 points sequentially despite FX headwinds
• Book value per share hit an all-time high of $16.91

---

Segment Breakdown

IGI writes a diversified portfolio across ~25 lines of business in 8 global offices:

Geographic Mix: 20% UK, 17% North America, 14% Europe, 12% Asia, 8% Middle East, and remainder across Africa, Latin America, and worldwide exposures.

Management noted continued focus on expanding reinsurance (60% of FY 2025 premium mix) where conditions remain strong, while maintaining discipline in more competitive short-tail and long-tail lines.

---

What's the Track Record?

IGI has delivered a 10-year CAGR of 8.1% in tangible book value per share plus dividends, with a 10-year average Core Operating ROE of 14.5%.

The company maintains a ~4 point combined ratio advantage versus specialty insurance peers over the 2016-2025 period.

---

Key Risks and Concerns

1. FX Volatility: FY 2025 results were negatively impacted by $24M of adverse foreign exchange movements. As a global insurer with exposures in GBP, EUR, and USD, currency swings can materially impact results.

2. Premium Contraction: Gross written premium declined 4.8% in FY 2025 as IGI exercised underwriting discipline. While prudent cycle management, prolonged premium decline could pressure growth.

3. Tariff Uncertainty: Management cited potential impact of U.S. tariffs on the insurance industry as a forward risk.

4. Long-Tail Reserve Development: While IGI has a history of favorable reserve development ($36M in FY 2025), the growing long-tail portfolio requires careful monitoring.

---

Forward Catalysts

1. Continued Capital Returns: With a $710M capital base, zero debt, and commitment to returning excess capital, shareholders can expect ongoing dividends and buybacks.

2. U.S. E&S Expansion: IGI continues building out its U.S. excess & surplus lines business from London and Bermuda platforms, a growth market.

3. Reinsurance Growth: Steady expansion of treaty reinsurance where market conditions remain favorable.

4. AI Investment: Management highlighted evaluation of AI technologies to improve underwriting efficiency.

---

The Bottom Line

IGI's Q4 2025 EPS miss obscures a solid quarter of execution. Net income grew 7.7% YoY, book value per share reached a record high (+13.9%), and the company returned $108 million to shareholders—its largest capital return year ever. The S&P upgrade to A (Stable) validates IGI's disciplined approach to underwriting and capital management.

While the 82.0% combined ratio is elevated versus Q4 2024's 77.8%, it remains well below the industry average and reflects IGI's ~4 point structural advantage. With zero leverage, a conservative investment portfolio, and 37% founder/family ownership, IGI continues to prioritize long-term value creation over short-term growth.

For investors focused on specialty insurance compounders, IGI's track record of 14.5% average ROE and 8.1% CAGR in tangible book value merits attention—even in a quarter that missed estimates.

---

Data sourced from IGI Q4 2025 Investor Presentation and S&P Global.